1,050 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
Here Are the Key Takeaways From J&J's Q1 Earnings Report http://www.zacks.com/stock/news/386860/here-are-the-key-takeaways-from-jjs-q1-earnings-report?cid=CS-ZC-FT-386860 Apr 18, 2019 - Let's have a look at some of the highlights of J&J's (JNJ) first-quarter 2019 results.
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus http://www.zacks.com/stock/news/382902/jnj-beats-ups-sales-growth-view-healthcare-etfs-in-focus?cid=CS-ZC-FT-382902 Apr 17, 2019 - Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast.
Stock Market News For Apr 17, 2019 http://www.zacks.com/stock/news/382742/stock-market-news-for-apr-17-2019?cid=CS-ZC--382742 Apr 17, 2019 - Markets closed higher on Tuesday as investors welcomed a spate of healthy first quarter earnings results.
Johnson & Johnson (JNJ) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/04/16/johnson-johnson-jnj-q1-2019-earnings-call-transcri.aspx?source=iedfolrf0000001 Apr 16, 2019 - JNJ earnings call for the period ending March 31, 2019.
Johnson & Johnson (JNJ) on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4254764-johnson-and-johnson-jnj-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts Apr 16, 2019 - Johnson & Johnson (NYSE:JNJ) Q1 2019 Earnings Conference Call April 16, 2019, 08:30 ET Company Participants Chris DelOrefice - VP, IR Joseph Wolk - EVP & CFO Jennifer Taubert - EVP & World
Story Stocks: Strength in pharma segment offsets stagnant consumer business for Johnson & Johnson (JNJ) http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=NS20190416114127StoryStocks Apr 16, 2019 - Before the open, Johnson & Johnson (JNJ) issued upside Q1 results and reaffirmed its outlook for FY1
J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View http://www.zacks.com/stock/news/382057/jj-jnj-beats-on-q1-earnings-ups-2019-sales-growth-view?cid=CS-ZC-FT-382057 Apr 16, 2019 - J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2019 and raises 2019 guidance for operational sales and adjusted operational EPS growth. Shares up in pre-market trading.
J&J (JNJ) Tops Q1 Earnings; Pharma Segment Drives Sales http://www.zacks.com/stock/news/381300/jj-jnj-tops-q1-earnings-pharma-segment-drives-sales?cid=CS-ZC-FT-381300 Apr 16, 2019 - J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2019. Hikes 2019 guidance for operational sales and earnings growth. Shares up in pre-market trading.
JNJ up 1% premarket on Q1 beat https://seekingalpha.com/news/3450947-jnj-1-percent-premarket-q1-beat?source=feed_news_all Apr 16, 2019 - Johnson & Johnson (JNJ) Q1 results: Revenues: $20,021M (+0.1%); Consumer: $3,318M (-2.4%); Pharmaceuticals: $10,244M (+4.1%); Medical Devices: $6,459M (-4.6%).Net Income: $3,749M (-14.2%); EPS: $1
Q1 Earnings To Watch For http://www.zacks.com/stock/news/382036/q1-earnings-to-watch-for?cid=CS-ZC--382036 Apr 16, 2019 - Q1 Earnings To Watch For

Pages: 1234567...105

<Page 2>